Affinity Asset Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.9M Sell
1,125,000
-225,000
-17% -$8.79M 2.66% 8
2026
Q1
$47.7M Buy
1,350,000
+350,000
+35% +$10.9M 2.47% 11
2025
Q4
$28M Sell
1,000,000
-250,000
-20% -$7.49M 1.59% 19
2025
Q3
$37.5M Buy
1,250,000
+250,000
+25% +$7.05M 3.27% 8
2025
Q2
$28.6M Hold
1,000,000
3.91% 8
2025
Q1
$33M Sell
1,000,000
-100,000
-9% -$3.26M 3.15% 8
2024
Q4
$31.6M Buy
1,100,000
+100,000
+10% +$2.87M 4.24% 5
2024
Q3
$28M Buy
1,000,000
+350,000
+54% +$9.33M 3.82% 6
2024
Q2
$15.7M Buy
650,000
+575,000
+767% +$14.1M 1.81% 15
2024
Q1
$2.03M Sell
75,000
-281,384
-79% -$7.99M 0.25% 73
2023
Q4
$9.89M Buy
356,384
+256,384
+256% +$6.66M 1.81% 21
2023
Q3
$2.8M Buy
+100,000
New +$2.93M 0.79% 39

Other funds holding ALKS

Affinity Asset Advisors's ALKS Position: Q2 2026 in Review

Affinity Asset Advisors reduced its Alkermes (ALKS) stake by 17% in Q2 2026, selling an estimated $8.79M and leaving 1,125,000 shares worth $58.9M. The position accounts for 2.66% of the portfolio, ranked #8.

Affinity Asset Advisors first reported a position in ALKS in Q3 2023 and has held it in 12 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Affinity Asset Advisors held 1,125,000 shares of Alkermes worth $58.9M as of Q2 2026.
  • Affinity Asset Advisors sold 225,000 Alkermes shares in Q2 2026, an estimated $8.79M.
  • Alkermes made up 2.66% of Affinity Asset Advisors's portfolio in Q2 2026, its #8 holding.
  • Affinity Asset Advisors first reported a position in Alkermes in Q3 2023 and has held it in 12 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Affinity Asset Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.